Furthermore, our applications of Inter-N-of-1 to infrequent oncogenic mutations (TP53 versus PIK3CA) of human breast cancer cohorts (Cancer Genome Atlas, 2012) exemplifies how micro-stratified common disorders present a computational ad biological sampling problem related to those observed in infrequent diseases and a proxy for rare disorders. This evidence concerns the gene TP53 and breast cancer.